Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MAD
2024-516379-34-00Phase 4Authorised
- Sponsor
- Erasmus MC
- Start
- Aug 2024
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of atropine in myopia (2 arms), sponsored by Erasmus MC. Primary endpoint: Axial length progression. Planned start Aug 2024; status: authorised.
02
Drugs
atropine
03
Conditions
myopia
Beyond the preview
Go deeper on 2024-516379-34-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-516379-34-00.